4.7 Article

A ratiometric electrochemical DNA-biosensor for detection of miR-141

Journal

MICROCHIMICA ACTA
Volume 189, Issue 6, Pages -

Publisher

SPRINGER WIEN
DOI: 10.1007/s00604-022-05301-w

Keywords

Biosensor; miR-141; Early Detection; Lung Cancer; Electrochemical biosensors

Funding

  1. Chemical Injuries Research Center and Applied Nano-biotechnology Research Center, Baqiyatallah University of Medical Sciences

Ask authors/readers for more resources

A sensitive biosensor has been developed for the detection of miR-141, which shows potential for early diagnosis of non-small cell lung cancer. The biosensor exhibited a low detection limit and a wide linear range, indicating its effectiveness in clinical applications.
A sensitive biosensor for the detection of miR-141 has been constructed. The DNA-biosensor is prepared by first immobilizing the thiolated methylene blue-labeled hairpin capture probe (MB-HCP) on two-layer nanocomposite film graphene oxide-chitosan@ polyvinylpyrrolidone-gold nanourchin modified glassy carbon electrode. We used the hematoxylin as an electrochemical auxiliary indicator in the second stage to recognize DNA hybridization via the square wave voltammetry (SWV) responses that record the accumulated hematoxylin on electrode surfaces. The morphology and chemical composition of nanocomposite was characterized using TEM, FE-SEM, and FT-IR techniques. The preparation stages of the DNAbiosensor were screened by electrochemical impedance spectroscopy and cyclic voltammetry. The proposed DNA-biosensor can distinguish miR-141 from a non-complementary and mismatch sequence. A detection limit of 0.94 fM and a linear range of 2.0 -5.0 x 10(5) fM were obtained using SWV for miR-141 detection. The working potential for methylene blue and hematoxylin was -0.28 and + 0.15 V vs. Ag/AgCl, respectively. The developed biosensor can be successfully used in the early detection of non-small cell lung cancer (NSCLC) by directly measuring miR-141 in human plasma samples. This novel DNA-biosensor is of promise in early sensitive clinical diagnosis of cancers with miR-141 as its biomarker.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available